• OPEN AN ACCOUNT
Indian Indices
Sensex
78,799.70 -1,439.15
( -1.79%)
Global Indices
Nasdaq
48,521.56 -404.23
(-0.83%)
Dow Jones
6,836.74 -65.88
(-0.95%)
Hang Seng
56,282.78 -1,774.46
(-3.06%)
Nikkei 225
10,473.49 -306.62
(-2.84%)
Forex
USD-INR
91.48 0.43
(0.47%)
EUR-INR
107.28 -0.27
(-0.25%)
GBP-INR
122.62 -0.09
(-0.07%)
JPY-INR
0.58 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
540204
INE666Q01016
42.7795752
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
23.15
71.74
EPS(TTM)
Face Value()
Div & Yield %
2.16
10
0
 

Edelweiss Financial Services plans to raise Rs 250 crore through NCD issue
Dec 04,2025
Edelweiss Financial Services has announced the public issue of 25 lakh Secured Redeemable Non-Convertible Debentures (NCDs) of the face value of Rs 1000 each for an amount aggregating up to Rs 250 crore.

The base size issue is Rs 125 crore, with an option to retain over-subscription up to an additional Rs 125 crore (Green Shoe Option) aggregating up to Rs 250 crore.

The issue is scheduled to open on 05 December 2025 and close on 18 December 2025, with an option of early closure or extension.

There are 10 series of NCDs carrying fixed coupons and having a tenure of 24 months, 36 months, 60 months and 120 months with monthly and annual interest payment options.

An effective yield (per annum) for the NCD holders in all categories of investors ranges from 8.85% to 10.10%.

The NCDs issue has been rated CRISIL A+/Stable by CRISIL.

The minimum application size for each application for NCDs would be 10 NCDs which is Rs 10,000 across all series collectively and in multiples of 1 NCD (Rs 1000) thereafter. Allotment is on First Come First Served Basis.

NCDs are proposed to be listed on BSE.